Presentation
Impacting Patient Outcomes Beyond the Minimum Requirements Set by Global Regulatory Standards for Medical Devices
DescriptionThe medical device industry is constantly innovating, with new devices designed years in advance to positively impact patient lives. However, despite these advancements, medical device use-errors remain a major global health challenge. Over the past 12 years, such errors have contributed to nearly 1.7 million injuries and almost 83,000 recorded deaths worldwide, and in the United States, they are the third leading cause of death. Despite this, many companies still perceive Human Factors (HF) primarily as a regulatory hurdle for approval, rather than a vital element of device safety and effectiveness.
The insights of this presentation involves examination of the commonalities and differences between the FDA, EU, and NMPA requirements, highlighting areas where these regulatory frameworks overlap and diverge. Building on this analysis, I propose a set of processes and methods that could be integrated into all three guidelines. These recommendations aim to standardize Human Factors assessment globally, ensuring a more consistent and thorough evaluation of device usability, safety, and patient impact. These insights are supported by contributions from industry professionals and regulatory experts, further emphasizing the notion of improving the existing standards.
Additionally, I analyze post-market surveillance data from a variety of sources (including FDA Recalls, MAUDE, BfArM, MHRA, PubMed, Europe PMC, and ClinicalTrials.gov) focusing on multiple approved medical devices that later faced recalls due to patient harm or death. This comprehensive review aims to identify common patterns and root causes behind these incidents. By examining the specific factors that contributed to these recalls, I explore how many of these issues could have been mitigated or avoided altogether with a proactive and refined approach to Human Factors during the design and development stages. The analysis emphasizes the importance of integrating Human Factors insights early on, illustrating how small shifts in methodology can significantly enhance device safety, reduce costly recalls, and ultimately protect and preserve patient health.
The key takeaway from this presentation is that industry professionals should view regulatory guidelines not as the maximum achievable standard of safety, but as the minimum standard requirement. Companies are encouraged to go beyond these baseline standards by leveraging the expertise of experienced and creative Human Factors practitioners, whose insights and innovative approaches can significantly enhance device safety and patient outcomes.
The insights of this presentation involves examination of the commonalities and differences between the FDA, EU, and NMPA requirements, highlighting areas where these regulatory frameworks overlap and diverge. Building on this analysis, I propose a set of processes and methods that could be integrated into all three guidelines. These recommendations aim to standardize Human Factors assessment globally, ensuring a more consistent and thorough evaluation of device usability, safety, and patient impact. These insights are supported by contributions from industry professionals and regulatory experts, further emphasizing the notion of improving the existing standards.
Additionally, I analyze post-market surveillance data from a variety of sources (including FDA Recalls, MAUDE, BfArM, MHRA, PubMed, Europe PMC, and ClinicalTrials.gov) focusing on multiple approved medical devices that later faced recalls due to patient harm or death. This comprehensive review aims to identify common patterns and root causes behind these incidents. By examining the specific factors that contributed to these recalls, I explore how many of these issues could have been mitigated or avoided altogether with a proactive and refined approach to Human Factors during the design and development stages. The analysis emphasizes the importance of integrating Human Factors insights early on, illustrating how small shifts in methodology can significantly enhance device safety, reduce costly recalls, and ultimately protect and preserve patient health.
The key takeaway from this presentation is that industry professionals should view regulatory guidelines not as the maximum achievable standard of safety, but as the minimum standard requirement. Companies are encouraged to go beyond these baseline standards by leveraging the expertise of experienced and creative Human Factors practitioners, whose insights and innovative approaches can significantly enhance device safety and patient outcomes.
Author
Event Type
Oral Presentations
TimeWednesday, March 258:52am - 9:15am EDT
LocationMurray Hill East
Patient Safety Research and Initiatives